SFRP4 and cancer: Whilst SFRP4 plasma expression was not predictive of outcome, its loss of expression from healthy to cancer still supports the findings achieved by RT-qPCR, Western-blot and IHC, and is probably mainly due to lower sample size and shorter follow-up data than our large IHC cohort.